ArticleJournal for immunotherapy of cancer2025

PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironment.

Lisa A King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.